文献速递质量管理与危急值临床生化

COVID-19 疫情下生化实验室运营考量与挑战:IFCC 全球调查

Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
PubMed 文献 · Clin Chem Lab Med · 2020-06-04

国际临床化学与检验医学联合会(IFCC)COVID-19 工作组开展全球电子问卷调查,分析生化实验室在疫情期间的运营考量与挑战。共纳入 1210 份有效提交,多数来自医院实验室。约 15% 实验室因生物安全顾虑限制疑似或确诊 COVID-19 患者的某些检测,略超 10% 因资源限制缩减检测菜单或服务。最突出的挑战是获取个人防护装备(PPE)、分析设备(含即时检验设备)、试剂、耗材等供应,其次是人员不足及士气、焦虑和部署管理。

要点

  • 约 15% 实验室因生物安全顾虑限制疑似或确诊 COVID-19 患者的某些检测。
  • 略超 10% 实验室因资源限制缩减检测菜单或服务。
  • 最突出挑战是 PPE、分析设备、试剂和耗材供应,其次是人员不足与士气管理。

核心结论

  • 限制检测和服务可能剥夺临床医生所需重要信息,带来不良临床后果。
  • 人员排班和生物安全顾虑需要长期解决方案,对疫情延长期间实验室持续运行至关重要。

研究设计与样本

  • IFCC COVID-19 工作组开展全球电子问卷调查,共纳入 1210 份有效提交,多数参与者来自医院实验室。

主要发现

  • 约 15% 实验室因生物安全顾虑限制疑似或确诊 COVID-19 患者的某些检测。
  • 略超 10% 实验室因资源限制缩减检测菜单或服务。
  • 约三分之一实验室进行体温监测,三分之二实验室增加消毒频率,略低于 50% 实验室拆分团队。
  • 最突出挑战是获取充足 PPE、分析设备(含即时检验设备)、试剂、耗材等供应。
  • 其次挑战是人员不足及管理其士气、焦虑和部署。

临床怎么用

  • 疫情期间应优先保障 PPE、分析设备、试剂和耗材供应,并制定人员排班与生物安全长期方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 conducted a global survey to understand how biochemistry laboratories manage the operational challenges during the coronavirus disease 2019 (COVID-19) pandemic. MATERIALS AND METHODS: An electronic survey was distributed globally to record the operational considerations to mitigate biosafety risks in the laboratory. Additionally, the laboratories were asked to indicate the operational challenges they faced. RESULTS: A total of 1210 valid submissions were included in this analysis. Most of the survey participants worked in hospital laboratories. Around 15% of laboratories restricted certain tests on patients with clinically suspected or confirmed COVID-19 over biosafety concerns. Just over 10% of the laboratories had to restrict their test menu or services due to resource constraints. Approximately a third of laboratories performed temperature monitoring, while two thirds of laboratories increased the frequency of disinfection. Just less than 50% of the laboratories split their teams. The greatest reported challenge faced by laboratories during the COVID-19 pandemic is securing sufficient supplies of personal protective equipment (PPE), analytical equipment, including those used at the point of care, as well as reagents, consumables and other laboratory materials. This was followed by having inadequate staff, managing their morale, anxiety and deployment. CONCLUSIONS: The restriction of tests and services may have undesirable clinical consequences as clinicians are deprived of important information to deliver appropriate care to their patients. Staff rostering and biosafety concerns require longer-term solutions as they are crucial for the continued operation of the laboratory during what may well be a prolonged pandemic.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Loh TP, Horvath AR, Wang CB, et al. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020. PMID: 32549122. doi:10.1515/cclm-2020-0710

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。